Clinical Trial Update: Dose Finding Confirmation of Atazanavir With Ritonavir and Efavirenz (ATV/RTV + EFV) in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 dose-finding study confirms the dose of atazanavir boosted with ritonavir and efavirenz in healthy subjects. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Norvir (ritonavir)
• REYATAZ (atazanavir)
• Sustiva (efavirenz)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: HIV Infections, Protease Inhibitor | Phase 1 | Status: COMPLETED